Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Schwann cell–derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment
Denise E. Allard, … , Steven S. Scherer, Maureen A. Su
Denise E. Allard, … , Steven S. Scherer, Maureen A. Su
Published September 17, 2018
Citation Information: J Clin Invest. 2018;128(10):4727-4741. https://doi.org/10.1172/JCI99308.
View: Text | PDF
Research Article Autoimmunity Neuroscience

Schwann cell–derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment

  • Text
  • PDF
Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain-Barre syndrome (GBS) are inflammatory neuropathies that affect humans and are characterized by peripheral nerve myelin destruction and macrophage-containing immune infiltrates. In contrast to the traditional view that the peripheral nerve is simply the target of autoimmunity, we report here that peripheral nerve Schwann cells exacerbate the autoimmune process through extracellular matrix (ECM) protein induction. In a spontaneous autoimmune peripheral polyneuropathy (SAPP) mouse model of inflammatory neuropathy and CIDP nerve biopsies, the ECM protein periostin (POSTN) was upregulated in affected sciatic nerves and was primarily expressed by Schwann cells. Postn deficiency delayed the onset and reduced the extent of neuropathy, as well as decreased the number of macrophages infiltrating the sciatic nerve. In an in vitro assay, POSTN promoted macrophage chemotaxis in an integrin-AM (ITGAM) and ITGAV-dependent manner. The PNS-infiltrating macrophages in SAPP-affected nerves were pathogenic, since depletion of macrophages protected against the development of neuropathy. Our findings show that Schwann cells promote macrophage infiltration by upregulating Postn and suggest that POSTN is a novel target for the treatment of macrophage-associated inflammatory neuropathies.

Authors

Denise E. Allard, Yan Wang, Jian Joel Li, Bridget Conley, Erin W. Xu, David Sailer, Caellaigh Kimpston, Rebecca Notini, Collin-Jamal Smith, Emel Koseoglu, Joshua Starmer, Xiaopei L. Zeng, James F. Howard Jr., Ahmet Hoke, Steven S. Scherer, Maureen A. Su

×

Figure 3

Postn deficiency protects against neuropathy.

Options: View larger image (or click on image) Download as PowerPoint

Postn deficiency protects against neuropathy.
NOD.SCIDPostn+/+, NOD.SCI...
NOD.SCIDPostn+/+, NOD.SCIDPostn+/–, and NOD.SCIDPostn–/– mice after AT with NOD.AireGW/+ activated splenocytes. NOD.SCID Postn–/– mice were compared with NOD.SCID Postn+/+ and NOD.SCID Postn+/– mice. (A) Neuropathy incidence curve shows the onset of clinical symptoms. Dotted line represents the time point at which mice were used in experiments (10 weeks after AT). (B) Representative CMAP traces 10 weeks after AT. The CMAP of the NOD.SCID Postn+/– nerve had a smaller amplitude and was more dispersed than that of the NOD.SCID Postn–/– nerve (note the difference in the y-axis scale: 2 vs. 20 mV). (C) Peak amplitude, (D) conduction velocity, and (E) duration of CMAPs for mice in A. Each dot represents an individual mouse. (F) Representative images of semithin sections of sciatic nerves from NOD.SCID Postn+/– (n = 8) and NOD.SCID Postn–/– (n = 3) recipients of NOD.AireGW/+ activated splenocytes. Original magnification, ×100. (G) The number of myelinated axons/1,000 μm2 was counted in cross sections of tibial nerves from NOD.SCID Postn+/– and NOD.SCID Postn–/– AT recipients. (H) EM images. Demyelinated axons (indicated by asterisks) were observed in the NOD.SCID Postn+/– nerve (n = 8), whereas the NOD.SCID Postn–/– (n = 3) nerve looked normal. Scale bar: 2 μm. (I) H&E staining of sciatic nerves. The NOD.SCID Postn+/– nerve was heavily infiltrated by hematoxylin-positive nuclei compared with the NOD.SCID Postn–/– nerve. Scale bar: 12 μm. (J) Infiltration scores were assigned as follows: 0 = no infiltration; 1 = 1%–25% of the nerve was infiltrated; 2 = 26%–50% of the nerve was infiltrated; 3 = 51%–75% of the nerve was infiltrated; 4 = 76%–100% of the nerve was infiltrated. Each dot represents an individual mouse. *P < 0.05 and **P < 0.005, by log-rank test (A), 2-tailed, unpaired t test with Welch’s correction (C–E and G), or Fisher’s exact test (J).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts